Multi-Drug Resistant Organisms

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Multi-Drug Resistant Organisms trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingPhase 2

NCT05835206

Further MT for Antibiotic-Resistant Bacterial Colonization

The purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistant…

United States40 participantsStarted 2024-04-25

Treatment: Microbiome Therapeutic, Placebo

RecruitingNot Applicable

NCT07134270

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

This study aims to evaluate the impact of digestive carriage of multidrug-resistant organisms (MDRO) on the risk of healthcare-associated infections in hospital…

Romania400 participantsStarted 2026-01-01

Treatment: MDRO Rectal Screening, 30-Day Telephone Follow-Up

RecruitingPhase 2

NCT06321536

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). REA…

United States60 participantsStarted 2025-01-13

Treatment: Allogeneic Microbiota in Glycerol (9%) (AMG)

RecruitingPhase 2/3

NCT04188743

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

Colonization by Multiple Drug Resistant Organisms (MDROs) during patient hospitalization requires expensive isolation measures and renders the return or transfe…

Belgium150 participantsStarted 2019-12-18

Treatment: Allogenic FMT, Autologous FMT

All recent trials (24 shown)

Not Yet RecruitingNot Applicable

NCT07505446

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Multidrug-resistant (MDR) bacteria represent a significant global health challenge, particularly among immunocompromised populations such as cancer patients und…

Location not specified100 participantsStarted 2026-05-01

Treatment: verapamil

CompletedNot Applicable

NCT07425561

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

This is a single-center, non-profit observational study with two sequential phases: an initial retrospective phase followed by a prospective phase. Patients wer…

Italy300 participantsStarted 2022-01-01

Treatment: RESPIRE score

Multi-Drug Resistant Organisms

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Further MT for Antibiotic-Resistant Bacterial Colonization

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

All recent trials (24 shown)

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Further MT for Antibiotic-Resistant Bacterial Colonization

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

All recent trials (24 shown)

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

Antibiotic Prophylaxis in Lung-Transplant Recipients

The Effect of Uroshield on Sputum-specimen Bacterial Growth

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

Sentinel Cohort REACT

The Relationship Between Renal Functions and Multi Drug Resistant Organisms

Multi-Drug Resistant Organism Network

Ventilator Associated Pneumonia by Multi-Drug Resistant Organism

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases

Using Antibiotics Wisely - An Antimicrobial Stewardship Program

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-d…

FMT for Multidrug Resistant Organism Reversal

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts A…

Rational Use of Personal Protective Equipment During COVID-19 Pandemic

Prevention of Nosocomial Infections (CleanKids)

Active Bathing to Eliminate Infection (ABATE Infection) Trial

Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)